- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
该股进入多头行情中，股价短线上涨概率较大。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有63家主力机构披露2026-06-30报告期持股数据，持仓量总计2.44亿股，占流通A股43.03%
- 波段诊断：
-
技术面诊股
诊断结果：6.6技术面打败了78%的股票
技术面评分前10的股票
近期的平均成本为12.59元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为12.59元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"12.59","date":1788770103,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，跑赢行业平均水平。
[{"date":"2026.09.08","stock":"0.64","trade":"1.65","ind":"0.20"},{"date":"2026.09.07","stock":"0.24","trade":"0.39","ind":"0.07"},{"date":"2026.09.04","stock":"0.00","trade":"-0.06","ind":"-0.30"},{"date":"2026.09.03","stock":"-0.24","trade":"-0.59","ind":"0.02"},{"date":"2026.09.02","stock":"-1.88","trade":"-1.51","ind":"-0.97"},{"date":"2026.09.01","stock":"1.67","trade":"1.64","ind":"-0.16"},{"date":"2026.08.31","stock":"-2.78","trade":"-1.74","ind":"0.86"},{"date":"2026.08.28","stock":"4.02","trade":"0.09","ind":"-0.11"},{"date":"2026.08.27","stock":"1.39","trade":"1.05","ind":"1.13"},{"date":"2026.08.26","stock":"0.41","trade":"0.81","ind":"0.59"},{"date":"2026.08.25","stock":"2.60","trade":"2.69","ind":"0.19"},{"date":"2026.08.24","stock":"-1.24","trade":"-1.70","ind":"-0.59"},{"date":"2026.08.21","stock":"-5.93","trade":"-3.27","ind":"0.04"},{"date":"2026.08.20","stock":"3.72","trade":"2.42","ind":"0.24"},{"date":"2026.08.19","stock":"-1.28","trade":"-1.50","ind":"-2.40"},{"date":"2026.08.18","stock":"-2.11","trade":"-1.04","ind":"0.19"},{"date":"2026.08.17","stock":"-1.16","trade":"0.49","ind":"1.41"},{"date":"2026.08.14","stock":"0.47","trade":"-0.81","ind":"0.01"},{"date":"2026.08.13","stock":"2.14","trade":"1.59","ind":"-0.50"},{"date":"2026.08.12","stock":"-0.47","trade":"0.14","ind":"0.32"},{"date":"2026.08.11","stock":"-0.55","trade":"0.34","ind":"-0.82"}]
康缘药业,上证指数,中药指数
压力支撑
该股压力位为12.55元，支撑位为12.45元。
[{"text":"\u538b\u529b\u4f4d","value":"12.55","date":1788796800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"12.45","date":1788796800,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.7资金面打败了45%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：09月08日 20:31
| 机构今日流向(万元) | 821.87 | 机构5日流向(万元) | -2406.90 |
| 机构10日流向(万元) | -6949.38 | 机构20日流向(万元) | -17815.50 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量减少2639.98万股，其中基金数没有增加，主力净减仓23家，请投资者中长期谨慎为宜。
截止2026-06-30，共63家主力机构（基金58家，一般法人4家，阳光私募1家），持仓量总计24362.84万股，占流通A股43.03%
其中，基金持仓与2025-12-31相比：
增仓：14家 ，增持 88.87万股
减仓：14家 ，减持 640.02万股
新出现在主力名单中：23家 ，持有605.85万股
从主力名单中消失：46家 ，原持有2387.69万股
其中，基金持仓与2025-12-31相比：
增仓：14家 ，增持 88.87万股
减仓：14家 ，减持 640.02万股
新出现在主力名单中：23家 ，持有605.85万股
从主力名单中消失：46家 ，原持有2387.69万股
消息面诊股
诊断结果：5.5消息面打败了51%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 这10家中药企业研发费用靠前，解锁产业增长新动能
2026-09-08 - 康缘药业：9月7日获融资买入324.36万元
2026-09-08 - 302家头部药企研发费用来了，百济、恒瑞、中生、石
2026-09-07 - 2026国家医保谈判正式启幕 中药企业首日抢先登场
2026-09-07 - 三天医保国谈的生意经：CAR-T赌支付，替尼守地盘
2026-09-07 - 2026国谈启动！CAR-T疗法再冲刺，阿尔茨海默
2026-09-07 - 直击医保国谈首日：中药与创新药企同日上桌，有人摇头
2026-09-05 - “很紧张，汗都出来了！”直击2025年国家医保谈判
2026-09-05 - 2026国谈首日上午场：多款中药品种开始谈判，华润
2026-09-05 - 2026年国家医保目录谈判今日开谈，首批进场企业包
2026-09-05
消息列表
| 一般消息 | 分红转增 | 不分配不转增 | 2026-08-28 |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-06-06 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-04-23 |
| 一般消息 | 重大事项 | 关联交易 | 2025-12-30 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-12-29 |
| 一般消息 | 重大事项 | 关联交易 | 2025-12-12 |
| 一般消息 | 高管变动 | 工作调整 | 2025-12-09 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-09-27 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.8行业面打败了71%的股票
中药行业最新资金流向
近10日来该行业走势不明显，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，接近大盘。
[{"date":"2026.09.08","price":"0.20","value":"1.65"},{"date":"2026.09.07","price":"0.07","value":"0.39"},{"date":"2026.09.04","price":"-0.30","value":"-0.06"},{"date":"2026.09.03","price":"0.02","value":"-0.59"},{"date":"2026.09.02","price":"-0.97","value":"-1.51"},{"date":"2026.09.01","price":"-0.16","value":"1.64"},{"date":"2026.08.31","price":"0.86","value":"-1.74"},{"date":"2026.08.28","price":"-0.11","value":"0.09"},{"date":"2026.08.27","price":"1.13","value":"1.05"},{"date":"2026.08.26","price":"0.59","value":"0.81"},{"date":"2026.08.25","price":"0.19","value":"2.69"},{"date":"2026.08.24","price":"-0.59","value":"-1.70"},{"date":"2026.08.21","price":"0.04","value":"-3.27"},{"date":"2026.08.20","price":"0.24","value":"2.42"},{"date":"2026.08.19","price":"-2.40","value":"-1.50"},{"date":"2026.08.18","price":"0.19","value":"-1.04"},{"date":"2026.08.17","price":"1.41","value":"0.49"},{"date":"2026.08.14","price":"0.01","value":"-0.81"},{"date":"2026.08.13","price":"-0.50","value":"1.59"},{"date":"2026.08.12","price":"0.32","value":"0.14"},{"date":"2026.08.11","price":"-0.82","value":"0.34"}]
上证指数,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 千金药业 | 49.60% | 10.77% | 6.4分 |
| 2 | 汉森制药 | 36.65% | -11.47% | 5.1分 |
| 3 | 精华制药 | 21.68% | 0.72% | 5.8分 |
| 4 | 沃华医药 | 17.13% | -2.58% | 6.4分 |
| 5 | 方盛制药 | 13.80% | -1.60% | 6.2分 |
| 6 | 粤万年青 | 12.98% | -0.58% | 5.4分 |
| 8 | 佛慈制药 | 10.75% | 0.57% | 6.0分 |
| 10 | 华森制药 | 7.17% | -2.66% | 5.1分 |
| 12 | 康惠股份 | 6.23% | 3.73% | 5.7分 |
| 14 | 亚宝药业 | 4.47% | 0.00% | 6.0分 |
| 16 | 维康药业 | 4.11% | 6.38% | 5.8分 |
| 18 | 康恩贝 | 3.24% | -1.33% | 5.9分 |
| 20 | 特一药业 | 3.01% | 5.05% | 5.9分 |
| 22 | 信邦制药 | 2.29% | 0.64% | 5.9分 |
| 24 | 益佰制药 | 2.09% | -5.78% | 5.0分 |
| 26 | 天目药业 | 1.40% | -3.20% | 6.1分 |
| 28 | 吉林敖东 | 1.16% | -2.24% | 6.1分 |
| 30 | 济川药业 | 0.82% | 1.02% | 6.4分 |
| 32 | 仁和药业 | 0.74% | -1.27% | 5.1分 |
| 34 | ST葫芦娃 | 0.00% | -0.33% | 4.5分 |
| 36 | 广誉远 | -0.64% | 0.22% | 5.7分 |
| 38 | 寿仙谷 | -1.37% | -1.50% | 5.3分 |
| 40 | 同仁堂 | -2.17% | 1.42% | 5.4分 |
| 42 | 九芝堂 | -2.56% | -0.76% | 6.3分 |
| 44 | 达仁堂 | -3.18% | -1.38% | 5.3分 |
| 46 | 马应龙 | -3.65% | -1.12% | 5.4分 |
| 48 | 昆药集团 | -4.54% | 0.12% | 5.4分 |
| 50 | 华润江中 | -5.56% | -2.14% | 5.6分 |
| 52 | 白云山 | -5.81% | 0.05% | 5.7分 |
| 54 | 天士力 | -6.31% | -1.42% | 5.3分 |
| 56 | 桂林三金 | -6.81% | -0.64% | 5.7分 |
| 58 | 振东制药 | -8.82% | -2.84% | 5.3分 |
| 60 | 东阿阿胶 | -10.35% | -1.51% | 5.1分 |
| 62 | 片仔癀 | -11.14% | 0.19% | 5.8分 |
| 64 | 葵花药业 | -12.82% | -0.50% | 4.7分 |
| 66 | 羚锐制药 | -13.35% | -1.21% | 5.6分 |
| 68 | 珍宝岛 | -17.77% | -0.70% | 4.9分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-06-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 33/109 ， 15/109。
[{"date":"2026-06-30","value":"3.01","vol":"3.25"},{"date":"2026-03-31","value":"1.63","vol":"2.21"},{"date":"2025-12-31","value":"6.51","vol":"-2.33"},{"date":"2025-09-30","value":"4.33","vol":"4.80"},{"date":"2025-06-30","value":"3.10","vol":"4.03"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
3.01 | 1.63 | 6.51 | 4.33 | 3.10 |
| 行业(%) | 3.25 | 2.21 | -2.33 | 4.80 | 4.03 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"72.91","vol":"53.70"},{"date":"2026-03-31","value":"74.97","vol":"55.05"},{"date":"2025-12-31","value":"71.44","vol":"52.85"},{"date":"2025-09-30","value":"69.47","vol":"53.29"},{"date":"2025-06-30","value":"70.88","vol":"53.82"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
72.91 | 74.97 | 71.44 | 69.47 | 70.88 |
| 行业(%) | 53.70 | 55.05 | 52.85 | 53.29 | 53.82 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 20/109 ， 28/109。
[{"date":"2026-06-30","value":"1.21","vol":"-9.08"},{"date":"2026-03-31","value":"-5.27","vol":"-5.58"},{"date":"2025-12-31","value":"-15.52","vol":"-6.76"},{"date":"2025-09-30","value":"-24.59","vol":"-7.84"},{"date":"2025-06-30","value":"-27.29","vol":"-7.78"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
1.21 | -5.27 | -15.52 | -24.59 | -27.29 |
| 行业(%) | -9.08 | -5.58 | -6.76 | -7.84 | -7.78 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"3.36","vol":"-101.51"},{"date":"2026-03-31","value":"-4.96","vol":"1.06"},{"date":"2025-12-31","value":"-22.44","vol":"-80.25"},{"date":"2025-09-30","value":"-35.63","vol":"-2.78"},{"date":"2025-06-30","value":"-40.12","vol":"2.25"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
3.36 | -4.96 | -22.44 | -35.63 | -40.12 |
| 行业(%) | -101.51 | 1.06 | -80.25 | -2.78 | 2.25 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 29/109 ， 30/109。
[{"date":"2026-06-30","value":"0.24","vol":"0.22"},{"date":"2026-03-31","value":"0.12","vol":"0.12"},{"date":"2025-12-31","value":"0.48","vol":"0.47"},{"date":"2025-09-30","value":"0.34","vol":"0.35"},{"date":"2025-06-30","value":"0.24","vol":"0.24"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.24 | 0.12 | 0.48 | 0.34 | 0.24 |
| 行业(次) | 0.22 | 0.12 | 0.47 | 0.35 | 0.24 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"1.05","vol":"1.14"},{"date":"2026-03-31","value":"0.46","vol":"0.59"},{"date":"2025-12-31","value":"1.89","vol":"2.34"},{"date":"2025-09-30","value":"1.45","vol":"1.72"},{"date":"2025-06-30","value":"0.96","vol":"1.17"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.05 | 0.46 | 1.89 | 1.45 | 0.96 |
| 行业(次) | 1.14 | 0.59 | 2.34 | 1.72 | 1.17 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 54/109 ， 63/109。
[{"date":"2026-06-30","value":"1.95","vol":"20.65"},{"date":"2026-03-31","value":"7.93","vol":"5.83"},{"date":"2025-12-31","value":"27.83","vol":"30.77"},{"date":"2025-09-30","value":"28.78","vol":"10.53"},{"date":"2025-06-30","value":"8.82","vol":"22.82"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 1.95 | 7.93 | 27.83 | 28.78 | 8.82 |
| 行业 | 20.65 | 5.83 | 30.77 | 10.53 | 22.82 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"2.53","vol":"0.88"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"2.63","vol":"1.00"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"2.10","vol":"1.03"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 2.53 | - | 2.63 | - | 2.10 |
| 行业 | 0.88 | 0.00 | 1.00 | 0.00 | 1.03 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 3/109 ， 35/109。
[{"date":"2026-06-30","value":"1.92","vol":"3.10"},{"date":"2026-03-31","value":"1.93","vol":"2.97"},{"date":"2025-12-31","value":"1.92","vol":"2.94"},{"date":"2025-09-30","value":"2.00","vol":"3.09"},{"date":"2025-06-30","value":"1.93","vol":"2.94"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.92 | 1.93 | 1.92 | 2.00 | 1.93 |
| 行业 | 3.10 | 2.97 | 2.94 | 3.09 | 2.94 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"1.63","vol":"2.34"},{"date":"2026-03-31","value":"1.61","vol":"2.23"},{"date":"2025-12-31","value":"1.60","vol":"2.15"},{"date":"2025-09-30","value":"1.69","vol":"2.24"},{"date":"2025-06-30","value":"1.62","vol":"2.15"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.63 | 1.61 | 1.60 | 1.69 | 1.62 |
| 行业 | 2.34 | 2.23 | 2.15 | 2.24 | 2.15 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 34/109 ， 38/109。
[{"date":"2026-06-30","value":"25.98","vol":"32.07"},{"date":"2026-03-31","value":"26.06","vol":"31.94"},{"date":"2025-12-31","value":"26.96","vol":"32.43"},{"date":"2025-09-30","value":"27.11","vol":"31.59"},{"date":"2025-06-30","value":"28.97","vol":"32.45"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
25.98 | 26.06 | 26.96 | 27.11 | 28.97 |
| 行业(%) | 32.07 | 31.94 | 32.43 | 31.59 | 32.45 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.36","vol":"0.68"},{"date":"2026-03-31","value":"0.37","vol":"0.66"},{"date":"2025-12-31","value":"0.38","vol":"0.67"},{"date":"2025-09-30","value":"0.39","vol":"0.76"},{"date":"2025-06-30","value":"0.43","vol":"0.75"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.36 | 0.37 | 0.38 | 0.39 | 0.43 |
| 行业(%) | 0.68 | 0.66 | 0.67 | 0.76 | 0.75 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 平安证券 | 2026-09-03 | 增持 | |
| 东吴证券 | 2026-08-30 | 买入 | |
| 华泰证券 | 2026-08-28 | 买入 | |
| 长城证券 | 2026-08-28 | 买入 |
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"4.34","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"4.64","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"3.92","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"3.04","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"3.47","blueLineValue":"0.61","type":"YC"}]